FDA Expands In-Person Face-to-Face Meetings for PDUFA, BsUFA, OMUFA

The FDA has expanded its use of in-person face-to-face (FTF) meetings for additional application types, and have expanded its definition of FTF meetings to include hybrid meetings which combine in-person and virtual attendance.
Source: Drug Industry Daily